title: N-nitroso-tris-chloroethylurea induces premalignant squamous dysplasia in mice.
abstract: Squamous cell carcinoma (SCC) and premalignant endobronchial lesions have been difficult to study in murine models. In this study, we evaluate the topical N-nitroso-tris-chloroethylurea (NTCU) murine SCC model, determine the extent to which resulting premalignant airway dysplasia develops, discuss clinicopathologic grading criteria in lesion progression, and confirm that immunohistochemical (IHC) staining patterns are consistent with those observed in human endobronchial dysplasia and SCC. Male and female FVB mice were treated biweekly with topical NTCU (4, 8, or 40 mmol/L) or vehicle for 32 weeks. Following sacrifice, squamous cell lesions were enumerated and categorized into the following groups: flat atypia, low-grade dysplasia, high-grade dysplasia, and invasive SCC. The 40 mmol/L NTCU concentration produced the entire spectrum of premalignant dysplasias and squamous cell carcinomas, but was associated with poor survival. Concentrations of 4 and 8 mmol/L NTCU were better tolerated and produced only significant levels of flat atypia. Squamous origin of the range of observed lesions was confirmed with IHC staining for cytokeratin 5/6, p63, thyroid transcription factor-1 (TTF-1), and Napsin-A. This study shows that topical application of high-dose NTCU produces endobronchial premalignant lesions with classic squamous characteristics and should allow for improved preclinical evaluation of potential chemopreventive agents.
authors.affiliation: Denver Veterans Affairs Medical Center, Department of Medicine, Denver, Colorado 80220, USA. robert.keith@va.gov
authors.forename: Tyler M
authors.initials: TM
authors.lastname: Hudish
authors.forename: Laura I
authors.initials: LI
authors.lastname: Opincariu
authors.forename: Anthony B
authors.initials: AB
authors.lastname: Mozer
authors.forename: Micah S
authors.initials: MS
authors.lastname: Johnson
authors.forename: Timothy G
authors.initials: TG
authors.lastname: Cleaver
authors.forename: Stephen P
authors.initials: SP
authors.lastname: Malkoski
authors.forename: Daniel T
authors.initials: DT
authors.lastname: Merrick
authors.forename: Robert L
authors.initials: RL
authors.lastname: Keith
mesh_terms: D000287:Administration, Topical; D000818:Animals; D001984:Bronchial Neoplasms / Q000139:chemically induced* / Q000401:mortality / Q000473:pathology; D002273:Carcinogens / Q000633:toxicity*; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced* / Q000401:mortality / Q000473:pathology; D002330:Carmustine / Q000031:analogs & derivatives* / Q000633:toxicity; D004195:Disease Models, Animal; D005260:Female; D007124:Immunoenzyme Techniques; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009361:Neoplasm Invasiveness; D011230:Precancerous Conditions / Q000139:chemically induced* / Q000401:mortality / Q000473:pathology; D015996:Survival Rate
chemical_list: D002273:Carcinogens; C572573:N-nitroso-tris-chloroethylurea; D002330:Carmustine
references.citation: Comp Med. 2008 Jun;58(3):253-63
references.pmid: 18589867
references.citation: Lung Cancer. 2001 Jun;32(3):265-79
references.pmid: 11390008
references.citation: Oncogene. 1999 Sep 20;18(38):5318-24
references.pmid: 10498884
references.citation: Semin Roentgenol. 2005 Apr;40(2):90-7
references.pmid: 15898407
references.citation: Lab Invest. 1985 Mar;52(3):243-56
references.pmid: 2579289
references.citation: Cancer Prev Res (Phila). 2009 May;2(5):440-9
references.pmid: 19401528
references.citation: Cancer Res. 1997 Jul 15;57(14):2832-4
references.pmid: 9230183
references.citation: Biochim Biophys Acta. 1997 Feb 28;1350(3):359-67
references.pmid: 9061032
references.citation: Cancer Res. 1992 May 1;52(9 Suppl):2670s-2676s
references.pmid: 1562998
references.citation: Hum Pathol. 2010 Jan;41(1):20-5
references.pmid: 19740516
references.citation: Mol Cancer Ther. 2010 Nov;9(11):3074-82
references.pmid: 21045137
references.citation: Cancer Res. 2007 Apr 1;67(7):3475-82
references.pmid: 17389758
references.citation: Cancer Cytopathol. 2010 Dec 25;118(6):441-9
references.pmid: 20830690
references.citation: Cancer Res. 2004 Mar 1;64(5):1647-54
references.pmid: 14996723
references.citation: Genes Dev. 1996 Jan 1;10(1):60-9
references.pmid: 8557195
references.citation: Cancer Prev Res (Phila). 2009 Jul;2(7):634-40
references.pmid: 19584077
references.citation: Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1526-31
references.pmid: 16896044
references.citation: Hum Pathol. 2002 Sep;33(9):921-6
references.pmid: 12378518
references.citation: Histopathology. 2002 May;40(5):403-39
references.pmid: 12010363
references.citation: Toxicology. 1989 Mar;54(3):241-71
references.pmid: 2650016
references.citation: J Thorac Oncol. 2009 Dec;4(12):1524-9
references.pmid: 19752759
references.citation: J Cancer Res Clin Oncol. 1988;114(3):245-9
references.pmid: 3384841
references.citation: Am J Clin Pathol. 2003 May;119(5):696-702
references.pmid: 12760288
references.citation: Exp Lung Res. 1998 Jul-Aug;24(4):541-55
references.pmid: 9659582
references.citation: Nucl Med Commun. 2007 Aug;28(8):647-52
references.pmid: 17625387
references.citation: CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
references.pmid: 20610543
references.citation: Genes Dev. 2001 Dec 15;15(24):3243-8
references.pmid: 11751630
references.citation: Adv Cancer Res. 1968;11:1-42
references.pmid: 4305560
references.citation: J Biol Chem. 2004 Apr 16;279(16):16178-84
references.pmid: 14766755
references.citation: J Biol Chem. 1995 Apr 7;270(14):8108-14
references.pmid: 7713914
references.citation: Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18514-9
references.pmid: 18000061
references.citation: Am J Physiol Cell Physiol. 2004 Jul;287(1):C171-81
references.pmid: 15189821
references.citation: Genes Dev. 2001 Dec 15;15(24):3249-62
references.pmid: 11751631
references.citation: Am J Surg Pathol. 2010 Dec;34(12):1805-11
references.pmid: 21107086